Sucano, Mel Christine .
HRN: 19-45-60 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2025
CEFUROXIME 1.5GM (VIAL)
06/30/2025
07/07/2025
IV
1.5g
Q8h
S/p CS
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: